Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia.
about
NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes.Unrelated donor bone marrow transplantation in adults: some current controversies.Therapy-related leukemia associated with alkylating agents.Therapy related leukemias: susceptibility, prevention and treatment.Unrelated donor hematopoietic transplantation.Stem cell transplantation for leukemias following myelodysplastic syndromes or secondary to cytotoxic therapy.NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic maRecent decrease in acute graft-versus-host disease in children with leukemia receiving unrelated donor bone marrow transplants.Tolerance after solid organ and hematopoietic cell transplantation.Review of stem-cell transplantation for myelodysplastic syndromes in older patients in the context of the Decision Memo for Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome emanating from the Centers for Medicare and MMyelodysplastic syndromes: clinical practice guidelines in oncology.Long-term follow-up after allogeneic stem cell transplantation in patients with myelodysplastic syndromes or secondary acute myeloid leukemia: a single center experience.Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens.Indications and timing of allogeneic bone marrow transplantation in myelodysplastic syndromes.Stem cells in hemato-oncology.First line therapy with fludarabine combinations in 42 patients with either post myelodysplastic syndrome or therapy related acute myeloid leukaemia.High-dose chemotherapy in high-risk myelodysplastic syndrome: covariate-adjusted comparison of five regimens.Age does not adversely influence outcomes among patients older than 60 years who undergo allogeneic hematopoietic stem cell transplant for AML and myelodysplastic syndrome.Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformation.Guidelines for the diagnosis and management of adult myelodysplastic syndromes.
P2860
Q33393647-57D2C640-FBFE-437C-8479-BC979AFEE74DQ33536887-2F03B136-AE25-4CC5-ADE0-91190EB3A95BQ34243510-32760133-6460-4B88-ABD2-AE02307D1961Q34265193-B6F010A7-BA17-4C18-96CE-7801D75A4709Q34326698-DAA8CD33-BDD3-48AA-A988-AE6997F24F69Q34680950-2CAA544B-B916-4097-8856-993DB821B774Q35605318-4C240EE3-79FE-4CFA-8289-B81B6C3121FEQ36002331-E61C9B30-ACC6-4BFA-A4DD-4D6565C75460Q36030385-CA5A110D-CBB7-4CDA-A47C-1CF61A5829C4Q36920394-B86FDF58-478F-490B-82E8-525DCD5495F6Q37723847-06B89B1E-E25A-463A-BE33-C3405394C3F6Q37730013-794D453C-39F0-4292-907B-2BBD40A5C0D9Q40573634-989578E1-CF14-4CB9-92D5-45B213350B87Q41709002-CA1A1E81-A8BF-49C6-93FA-F674A1E41AD7Q41902244-B05CCC97-176A-4055-939F-EBB63FEACB54Q43653720-B0D3A0D8-A683-4E0B-B3E4-D3A1592B6E69Q43763239-C60D2877-0139-4F06-9AD5-68D7F9AB48D6Q48133412-AF11EF37-74F6-466E-B4C8-EF47613995ACQ53361889-A0882023-4872-4CBB-9127-481A9E2EBEA5Q54392826-ABC58D50-6046-4FF5-817C-E6F81BFB7BA1
P2860
Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Unrelated donor marrow transpl ...... lated acute myeloid leukaemia.
@en
type
label
Unrelated donor marrow transpl ...... lated acute myeloid leukaemia.
@en
prefLabel
Unrelated donor marrow transpl ...... lated acute myeloid leukaemia.
@en
P2093
P50
P1476
Unrelated donor marrow transpl ...... lated acute myeloid leukaemia.
@en
P2093
C Anasetti
J A Hansen
J E Anderson
J E Sanders
K M Sullivan
T A Gooley
P356
10.1046/J.1365-2141.1996.4811022.X
P407
P577
1996-04-01T00:00:00Z